J. Henri Bayle
Chief Tech/Sci/R&D Officer at BELLICUM PHARMACEUTICALS, INC.
Profile
J.
Henri Bayle is currently working as the Vice President-Research at Bellicum Pharmaceuticals, Inc. He completed his undergraduate degree from the University of Alberta and his doctorate from Princeton University.
J. Henri Bayle active positions
| Companies | Position | Start |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2013 |
Training of J. Henri Bayle
| University of Alberta | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- J. Henri Bayle
